Health technology assessment in India in the next decade: reflections on a vision for its path to maturity and impact ...

Drug treatment to reduce cholesterol to new target levels is now recommended in four moderate- to high-risk patient populations: patients who have already sustained a cardiovascular event, adult ...

Correspondence to Dr Elaine Lehane, Catherine McAuley School of Nursing and Midwifery, University College Cork, Cork T12 K8AF, Ireland; e.lehane{at}ucc.ie To highlight and advance clinical ...

Objectives Systematic reviews and meta-analyses are the foundation of modern evidence-based medicine and their use is becoming more prolific than randomised trials. However, systematic reviews are ...

1 Department of Internal Medicine and Clinical Epidemiology, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia 2 Centre for Academic Research in Geriatric Medicine ...

Correspondence to Sir Iain Chalmers, James Lind Initiative, Summertown Pavilion, Middle Way, Oxford OX2 7LG, UK; ichalmers{at}jameslind.net We are surrounded by maelstroms of claims about the effects ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Correspondence to: Dr Mary Bond PenTAG, Peninsula Medical School, University of Exeter, Veysey Building, Salmon Pool Lane, Exeter EX2 4SG, Devon, UK; mary.bond{at}pms.ac.uk The negative psychological ...

Correspondence to Dr Kerry Dwan, Centre for Reviews and Dissemination, University of York, York, UK; Kerry.dwan{at}york.ac.uk A systematic review identifies, appraises and synthesises all the ...

Correspondence to Professor Friedemann Geiger, National Competency Center for Shared Decision Making, University Hospital Schleswig-Holstein, Kiel, Germany; f.geiger{at}uksh.de We developed The Six ...

Correspondence to Professor J. David Spence, Stroke Prevention and Atherosclerosis Research Centre, Robarts Research Institute, Western University, London, ON, N6G 2V4, Canada; dspence{at}robarts.ca ...

Objectives To examine the association between regulatory reviewer disagreements and postmarket safety actions among novel therapeutics approved by the US Food and Drug Administration (FDA) between ...